CCM
IDXX icon

Chiron Capital Management’s Idexx Laboratories IDXX Stock Holding History

Chiron Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5
Closed -$2K – 240
2020
Q3 		$2K Buy
+5
New +$1.85K ﹤0.01% 442

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Chiron Capital Management's IDXX Position: Q4 2020 in Review

Chiron Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2020, closing a stake of 5 shares — an estimated $2K sold.

Chiron Capital Management first reported a position in IDXX in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 971 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

  • Chiron Capital Management reported no remaining Idexx Laboratories position as of Q4 2020 after selling out during the quarter.
  • Chiron Capital Management sold 5 Idexx Laboratories shares in Q4 2020, an estimated $2K.
  • Chiron Capital Management first reported a position in Idexx Laboratories in Q3 2020 and held it in 1 quarter.
  • Chiron Capital Management's Idexx Laboratories position peaked at $2K in Q3 2020.
  • 971 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.